Fennec Pharmaceuticals Inc. (FENC)
NASDAQ: FENC · Real-Time Price · USD
4.640
+0.365 (8.54%)
Nov 20, 2024, 4:00 PM EST - Market closed
Fennec Pharmaceuticals Employees
Fennec Pharmaceuticals had 29 employees as of December 31, 2023. The number of employees decreased by 7 or -19.44% compared to the previous year.
Employees
29
Change (1Y)
-7
Growth (1Y)
-19.44%
Revenue / Employee
$1,701,655
Profits / Employee
-$39,069
Market Cap
127.29M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Coherus BioSciences | 306 |
Protalix BioTherapeutics | 208 |
Zomedica | 144 |
Adverum Biotechnologies | 121 |
TriSalus Life Sciences | 112 |
Compugen | 68 |
Eupraxia Pharmaceuticals | 29 |
Zentek | 24 |
FENC News
- 8 days ago - Fennec Pharmaceuticals to Participate in Upcoming Investor Conference - GlobeNewsWire
- 11 days ago - Fennec Pharmaceuticals Inc. (FENC) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 14 days ago - Fennec Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 21 days ago - Fennec Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 7, 2024 - GlobeNewsWire
- 24 days ago - Fennec Pharmaceuticals Strengthens Executive Leadership Team with Three Key Appointments to Accelerate the Company's Next Stage of Growth - GlobeNewsWire
- 2 months ago - Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 3 months ago - Fennec Pharmaceuticals Inc. (FENC) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Fennec Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update - GlobeNewsWire